Elise deluche Profile
Elise deluche

@elisedeluche

Followers
43
Following
106
Media
1
Statuses
14

Joined July 2010
Don't wanna be here? Send us removal request.
@elisedeluche
Elise deluche
4 years
0
1
1
@FAndreMD
FabriceAndre
4 years
Don’t forget to vote for @myESMO election of the Executive Board, including the new President Elect. Link below ! Next EB needs a strong support and engagement. Oncology is currently facing major challenges that can be ,at least partially, addressed by @myESMO .
@myESMO
ESMO - Eur. Oncology
4 years
"Cast your votes for the Executive Board candidates that best represent you & will guide our Society to support you as #oncology professionals & fulfil our mission to take the best possible care of our patients" @peters_solange ESMO members 📢 Vote here https://t.co/IwFyaYxMbO
0
11
24
@matteolambe
Matteo Lambertini, MD PhD
4 years
Another great reason to follow @SABCSSanAntonio #SABCS21: super congratulations @FAndreMD !!!! 👏👏👏👏👏 @OncoAlert @AACR
@SABCSSanAntonio
SABCS
4 years
Helen Piwnica-Worms, PhD and Fabrice André, MD, PhD are the #SABCS21 recipients of the @AACR awards for their contributions to breast cancer research. See more at our blog. https://t.co/m9BOKrroHi
1
3
27
@FAndreMD
FabriceAndre
4 years
Preliminary OS results of MonarchE in overall pop and in the pop where the drug is approved by FDA . MonarchE assessed efficacy of Abemaciclib , a CDK4/6 inh in pts with HR+/her2- eBC https://www.annalsofoncology.org/article/S0923-7534(21)04551-8/fulltext#.YXxIy37LgUA.twitter
2
20
53
@ClinOncNews
ClinicalOncologyNews
4 years
.@US_FDA approves #Verzenio @LillyPad with endocrine therapy for adjuvant treatment of adults who have early breast cancer. https://t.co/BDVkbjsyfm @stolaney1 @DanaFarber #abemaciclib #breastcancer #fda
0
1
2
@BenedettaGuani
Benedetta Guani
4 years
Our 4 posters at the ESGO Congress! @elisedeluche @SfogC @la_sfog @CHUVLausanne @unil
0
4
10
@CHULimoges
CHU de Limoges
4 years
Ce 18 octobre, le #chudelimoges et l'Université de Limoges @unilim ont signé la convention constitutive du Groupement d‘Intérêt Scientifique relative à l’Institut de Simulation Pour l’Etude l’Application et la Recherche en Santé InsPEARS.
1
13
28
@JNeurooncol
Journal of Neuro-Oncology
4 years
Should elderly patients with #GBM undergo surgical resection? Researchers at @YNeurosurgery have found that aggressive resection improves OS and functional outcomes and should be considered in this population. #JNO #BTSM #Neurosurgery https://t.co/KXKMwxE6bF
2
7
17
@Annals_Oncology
Annals of Oncology
4 years
Abemaciclib + endocrine therapy for early breast cancer was approved by @FDAOncology based on the monarchE study. Results of the the primary outcome analysis presented at the #ESMOVirtualPlenary are available #openaccess in @Annals_Oncology https://t.co/I5kFGN3NBJ #bcsm
1
67
124
@SfogC
SFOG campus
5 years
Medical or surgical professionnals involved in ovarian cancer treatment, please takes 5 minutes to answer our survey on management of advanced ovarian cancer!!#oncoAlert ⬇️
docs.google.com
In order to evaluate and standardize the management of advanced ovarian cancer in Europe, members of the Campus of French Society of Gynecological Oncology (SFOG) have developed a survey for medical...
0
4
4